•
Sep 30, 2017

Corcept Therapeutics Q3 2017 Earnings Report

Total Revenue
$42.8M
Previous year: $21.7M
+96.8%
EPS
$0.14
Previous year: $0.04
+250.0%
Gross Profit
$41.8M
Previous year: $21.1M
+98.4%
Cash and Equivalents
$31.1M
Previous year: $47.9M
-35.1%
Free Cash Flow
$10.8M
Total Assets
$111M
Previous year: $62.9M
+75.9%

Corcept Therapeutics

Corcept Therapeutics